Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of methylation sites in SHH myeloblastoma

A medulloblastoma, methylation technology, applied in biochemical equipment and methods, microbial determination/inspection, DNA/RNA fragments, etc., can solve the problems of easy degradation, long analysis period and high cost

Active Publication Date: 2019-05-21
GUANGZHOU KINGMED DIAGNOSTICS CENT +2
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the current diagnosis of SHH medulloblastoma mainly refers to its gene expression profile, which requires RNA transcriptome sequencing, which is costly and takes a long period of experiment and analysis. Because RNA is easily degraded, the technical requirements for experimental operations are also high, so the experiment failed. Both the rate and the experimental error are relatively high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of methylation sites in SHH myeloblastoma
  • Application of methylation sites in SHH myeloblastoma
  • Application of methylation sites in SHH myeloblastoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Sample collection and testing.

[0042] 1. Sample collection.

[0043] Collect 223 postoperative tissue samples from patients with SHH-type medulloblastoma, and 540 postoperative tissue samples from patients with other types of medulloblastoma except SHH, that is, OTHERS samples (including other subtypes of medulloblastoma: WNT, Group3 and Group4).

[0044] 2. Sample testing.

[0045] The commercial Illumina HumanMethylation450 BeadChip chip was used to detect methylation, and the routine experimental procedures were followed. The main experimental procedures include:

[0046] 1. Extract sample DNA and amplify;

[0047] 2. Use enzymes to break DNA to fragment it;

[0048] 3. Separation and purification of DNA fragments and addition of adapters;

[0049] 4. Hybridization of DNA fragments with chips;

[0050] 5. On-chip detection on the chip.

Embodiment 2

[0052] Screening for methylation sites.

[0053] 1. Preliminary screening of methylation sites.

[0054] Using the data in Example 1 as the database, first establish a model based on a single methylation site, and then select highly differentiated methylation sites to build a comprehensive model based on a series of methylation sites. Then, according to the b-value value of the selected methylation site (one or more), the eigenvalue vector of a sample is constructed, and each sample corresponds to a tumor type (SHH type medulloblastoma or OTHERS), by This establishes a SVM classification model, and then obtains the methylation sites with significant differences, as shown in the following table.

[0055] Table 1. Methylation sites with significant differences between SHH medulloblastoma and OTHERS

[0056] site

Gene

Chromosome

Locus Chromosomal Coordinates

positive / negative chain

cg20419291

ROBO4

chr11

124767974

+

cg0968442...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of methylation sites in SHH medulloblastoma, belongs to the technical field of tumor typing detection, and particularly relates to an application of a methylation degree reagent of at least one gene site in ROBO4, OTX2OS1, AHRR, DKK4 and PART1 genes in a biological sample in preparation of a diagnostic reagent or diagnostic equipment for SHH type medulloblastoma. By analyzing and comparing data of a large number of SHH type myeloblastoma samples and other types of samples, the inventor finds that the methylation degree of the sites in the genes can be used as a reference index for diagnosing the SHH type myeloblastoma, and the SHH type of the myeloblastoma can be typed and confirmed only by directionally detecting a plurality of methylation sites, sothat the diagnosis difficulty of the SHH type myeloblastoma is reduced, and the cost is reduced.

Description

technical field [0001] The invention relates to the technical field of tumor typing and detection, in particular to the application of a SHH type medulloblastoma methylation site. Background technique [0002] Medulloblastoma is the most common malignant brain tumor in children. About 85% of medulloblastoma occurs in children under the age of 18, and 1 in every 5 children with brain tumors has medulloblastoma . In recent years, the survival rate of patients with medulloblastoma has improved, but the mortality rate is still high, and neurological and endocrine sequelae often occur in patients with successful treatment. [0003] The incidence of medulloblastoma is about 0.71 / 100,000 people. In the United States, 400 to 500 children suffer from the disease every year. The peak incidence of the disease is between 3 and 6 years old. It is very rare in people after the age of 50. There is no report on the influence of biochemical environment on the incidence of medulloblastoma. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12N15/11C12Q1/6886C12Q2600/154
Inventor 刘晶星赵薇薇王怡摄孙明明陈白雪胡昌明于世辉
Owner GUANGZHOU KINGMED DIAGNOSTICS CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com